Global Coronavirus Crisis: monitoring and impacts
DOI:
https://doi.org/10.9771/cp.v13i2.35937Keywords:
Pandemic, SARS-CoV-2, Prospection.Abstract
On March 11, 2020, the World Health Organization declared that the world was experiencing a pandemic due to the new coronavirus. The objective of this work was to analyze the panorama of research and public policies focused on COVID-19, mapping the development of technologies related to the theme. The research had a descriptive and exploratory character, when analyzing informations from bibliographic references, focusing on the PubMed repository. The quantitative technological prospecting about coronavirus, through 06 patent sources, complements this qualitative analysis. With the global crisis caused by COVID-19, the production of knowledge and digital platforms has been extremely accelerated in a short time. Virtually all countries were affected by the pandemic, and those who understood the seriousness of the situation more quickly, and implemented assertive policies and technologies, were able to mitigate short-term impacts, especially with regard to preserving lives.
Downloads
References
ANDERSEN, K.G.; RAMBAUT, A.; LIPKIN, W.I. et al. The proximal origin of SARS-CoV-2. Nat Med .2020. https://doi.org/10.1038/s41591-020-0820-9
ANDRINO, B.; GRASSO, D.; LLANERAS, K. Assim evolui a curva do coronavírus no Brasil e no resto da América Latina. https://brasil.elpais.com/brasil/2020/03/18/ciencia/1584535031_223995.html. Acesso em 25 mar.2020.
BBC News. Coronavírus e "sopa de morcego"? Teoria de conspiração e fake news se espalham com avanço de surto https://www.bbc.com/portuguese/internacional-51311226. Acesso em: 19 mar. 2020.
BRASIL. DIÁRIO OFICIAL DA UNIÃO (DOU). PORTARIA Nº 188, DE 3 DE FEVEREIRO DE 2020.Disponível em http://www.in.gov.br/en/web/dou/-/portaria-n-188-de-3-de-fevereiro-de-2020-241408388. Acesso em: 19 mar. 2020.
BERTRAM, S.; GLOWACKA, I.; MÜLLER, M. A.; LAVENDER, H.; GNIRSS, K.; NEHLMEIER, I.; ... & SOILLEUX, E. J. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. Journal of virology, v. 85, n. 24, p. 13363-13372, 2011.
BEDFORD, J. et al. COVID-19: towards controlling of a pandemic. Elsevier, 2020. Disponível em: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30673-5/fulltext. Acesso em: 17 de mar. de 2020.
BOZZATO, G.; GONÇALVES, S. Isolamento deve custar caro à economia, mas a falta dele pode ser pior. 2020. https://www.agazeta.com.br/es/economia/isolamento-deve-custar-caro-a-economia-mas-a-falta-dele-pode-ser-pior-0320. Acesso em: 28 mar. 2020.
CANDIDO, D.; WATTS, A.; ABADE, L. et al. Routes for COVID-19 importation in Brazil, Journal of Travel Medicine. 042, 2020. https://doi.org/10.1093/jtm/taaa042
CAPITANI, L. Coronavírus: por que o distanciamento social é importante? https://www.minhavida.com.br/saude/materias/36067-coronavirus-por-que-o-distanciamento-social-e-importante. Acesso em: 26 mar. 2020.
CARVALHO, N. Governo anuncia mais medidas para reduzir o impacto do COVID-19. https://agenciabrasil.ebc.com.br/politica/noticia/2020-03/governo-anuncia-mais-medidas-para-reduzir-impacto-do-covid-19. Acesso em: 28 mar.2020.
CHENG, V. C.; LAU, S. K.; WOO, P. C.; & YUEN, K. Y. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clinical microbiology reviews, v. 20, n. 4, p. 660-694, 2007.
CORMAN, V.M.; LANDT, O.; KAISER, M. et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill.25, 2020.
CORREIA, S.; LUCK, S.; VERNER, E. Pandemics Depress the Economy, Public Health Interventions Do Not: Evidence from the 1918 Flu (March 26, 2020). Available at SSRN: https://ssrn.com/abstract=3561560 or http://dx.doi.org/10.2139/ssrn.3561560
CUI, J.; LI, F.; SHI, Z.L. Origin and evolution of pathogenic coronaviruses. Nature reviews. Microbiology. 2019 Mar;17(3):181-192. DOI: 10.1038/s41579-018-0118-9.
DOMINGUEZ, S. R.; O’SHEA, T. J.; OKO, L. M.; & HOLMES, K. V. Detection of group 1 coronaviruses in bats in North America. Emerging infectious diseases, v. 13, n. 9, p. 1295, 2007.
FERGUSON, N.M.; LAYDON, D.; NEDJATI-GILANI, G.; IMAI, N. et al. Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imperial College COVID-19 Response Team. 2020. https://doi.org/10.25561/77482
FEHR, A. R.; PERLMAN, S. Coronaviruses: an overview of their replication and pathogenesis. In: Coronaviruses. Humana Press, New York, NY, p. 1-23, 2015.
FERNANDEZ, M. Economia global em quarentena. 2020. Jornal El País. Seção Economia. https://brasil.elpais.com/economia/2020-03-09/economia-global-em-quarentena.html. Acesso em: 19 mar. 2020.
GILBERT, M. et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study. Lancet. v.395, p.871–877, 2020.
GLOWACKA, I.; BERTRAM, S.; MÜLLER, M. A.; ALLEN, P.; SOILLEUX, E.; PFEFFERLE, S.; ... NIEMEYER, D. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of virology, v. 85, n. 9, p. 4122-4134, 2011.
HUANG, C., WANG, Y.; LI, X.; REN, L.; ZHAO, J.; HU, Y.; ... & CHENG, Z. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet, v. 395, n. 10223, p. 497-506, 2020.
KHOT, W. Y.; & NADKAR, M. Y. The 2019 Novel Coronavirus Outbreak–A Global Threat. Journal of The Association of Physicians of India, v. 68, p. 67, 2020.
KRAEMER, M.U.G et al. The effect of human mobility and control measures on the COVID-19 epidemic in China. Science 25 Mar 2020:eabb4218. DOI: 10.1126/science.abb4218.
KUHN, A. South Korea's Drive-Through Testing For Coronavirus Is Fast — And Free. 2020.https://www.npr.org/sections/goatsandsoda/2020/03/13/815441078/south-koreas-drive-through-testing-for-coronavirus-is-fast-and-free. Acesso em 18 mar.2020
LI, B.; SI, H. R.; ZHU, Y.; YANG, X. L.; ANDERSON, D. E.; SHI, Z. L.; ... & ZHOU, P. Discovery of Bat Coronaviruses through Surveillance and Probe Capture-Based Next-Generation Sequencing. MSphere, v. 5, n. 1, 2020a.
LU, R., ZHAO, X.; LI, J.; NIU, P.; YANG, B.; WU, H.; ... & BI, Y. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The Lancet, v. 395, n. 10224, p. 565-574, 2020.
MEYER, B.; DROSTEN, C.; MÜLLER, M.A.Serological assays for emerging coronaviruses: challenges and pitfalls.Virus Res. 2014 Dec 19;194:175-83.
MINISTÉRIO DA SAÚDE. Coronavírus: 6 mortes e 621 casos confirmados. 19 mar. 2020. < https://saude.gov.br/>. Acesso em: 19 mar.2020.
MORENS, D. M.; FOLKERS, G. K.; FAUCI, Anthony S. What is a pandemic? The Journal of Infectious Diseases, v. 200, n. 7, p. 1018–1021. 2009.
MURRAY, A. Coronavírus: os robôs usados para eliminar vírus em hospitais.BBC News Brasil.2020. https://www.bbc.com/portuguese/geral-52038851. Acesso em: 29. mar. 2020.
NORDLING, L. ‘A ticking time bomb’: Scientists worry about coronavirus spread in Africa. Disponível em: https://www.sciencemag.org/news/2020/03/ticking-time-bomb-scientists-worry-about-coronavirus-spread-africa. Acesso em: 21 mar. 2020.
ONU BRASIL. Brasil confirma primeiro caso de infecção pelo novo coronavírus. 27 fev. 2020.< https://nacoesunidas.org/brasil-confirma-primeiro-caso-de-infeccao-pelo-novo-coronavirus/amp/>. Acesso em: 16 mar. 2020.
ORBIT. 2020. Disponível em: https://www.questel.com/business-intelligence-software/orbitintelligence/.Acesso em: 18 mar. 2020.
PERLMAN, S.; NETLAND, J. Coronaviruses post-SARS: update on replication and pathogenesis. Nature reviews microbiology, v. 7, n. 6, p. 439-450, 2009.
QUINTELLA, C. M. et al. Vacinas para Coronavírus (COVID-19; SARSCOV-2): mapeamento preliminar de artigos, patentes, testes clínicos e mercado. Cadernos de Prospecção v.13 (1). 2020. DOI: http://dx.doi.org/10.9771/cp.v13i1.35871
SANTIRSO, J. Coreia do Sul: contra o coronavírus, tecnologia.2020 https://brasil.elpais.com/internacional/2020-03-15/coreia-do-sul-contra-o-coronavirus-tecnologia.html. Acesso em: 19 mar. 2020.
SHAOLI, B.; JIANYUN, W.; YINGQUAN, Z.; DESHENG, Y.; XIAOMIN, G.; LINGLING, L.; FAN, Y. Analysis of the first family epidemic situation of new coronavirus pneumonia in Gansu Province. Chinese Journal of Preventive medicine, 2020, 54.
SHEREEN, M. A.; KHAN, S.; KAZMI, A.; BASHIR, N.; SIDDIQUE, R. COVID-19 infection: origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research, 2020.
SIBYLLE, B. S. et al. Investigation team. First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures. Euro surveillance, v.25, 2020.
STEVENS, J. Airborne Nitrogen Dioxide Plummets Over China. Nacional Aeronautics and Space Administration.2020.https://earthobservatory.nasa.gov/images/146362/airborne-nitrogen-dioxide-plummets-over-china. Acesso em: 19 mar. 2020.
SU, S.; WONG, G.; SHI, W.; LIU, J.; LAI, A. C.; ZHOU, J.; ... & GAO, G. F. Epidemiology, genetic recombination, and pathogenesis of coronaviruses. Trends in microbiology, v. 24, n. 6, p. 490-502, 2016.
UFMG. UFMG participa do sequenciamento de 19 genomas do coronavírus. https://ufmg.br/comunicacao/noticias/pesquisadores-de-ufmg-ufrj-e-lncc-sequenciam-genoma-de-19-exemplares-do-covid-19 Acesso em: 26 mar. 2020.
UNA/SUS. Universidade Aberta do Sistema Único de Saúde. 2020 https://www.unasus.gov.br/noticia/organizacao-mundial-de-saude-declara-pandemia-de-coronavirus. Acesso em: 15 mar.2020.
VELAVAN, T. P.; & MEYER, C. G. The COVID‐19 epidemic. Tropical Medicine & International Health, 2020.
WANG, S.; KANG, B.O.; JINLU, M.A.; ZENG, X.; XIAO, M.; GUO, J.; CAI, M. et al. A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19). medRxiv 2020.02.14.20023028; doi:https://doi.org/10.1101/2020.02.14.20023028
WANG, D. et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. v.11, p.1061-1069, 2020.
WHO EUROPE. Joint WHO and ECDC mission in Italy to support COVID-19 control and prevention efforts. 24 fev. 2020a. < http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/2/joint-who-and-ecdc-mission-in-italy-to-support-covid-19-control-and-prevention-efforts>. Acesso em: 16 mar. 2020.
WHO. Novel Coronavirus (COVID-19). Situation report -11. 31 jan. 2020b. <https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200131-sitrep-11-ncov.pdf?sfvrsn=de7c0f7_4 >. Acesso em: 16 mar. 2020.
WHO. Novel Coronavirus (COVID-19). Situation report – 57.17 mar. 2020c. <https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200317-sitrep-57-covid-19.pdf?sfvrsn=a26922f2_4 >. Acesso em: 18 mar. 2020.
WHO. Novel Coronavirus (COVID-19). Situation report – 36. 25 fev. 2020d. <https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200225-sitrep-36-covid-19.pdf?sfvrsn=2791b4e0_2>. Acesso em: 16 mar. 2020.
XIAO, S.Y.; WU, Y.; LI, J. Evolving status of the 2019 novel coronavirus infections: proposal of conventional serologic assays for disease diagnostics and infection monitoring. J Med Virol. 1-4, 2020.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Cadernos de Prospecção
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
O autor declara que: - Todos os autores foram nomeados. - Está submetendo o manuscrito com o consentimento dos outros autores. - Caso o trabalho submetido tiver sido contratado por algum empregador, tem o consentimento do referido empregador. - Os autores estão cientes de que é condição de publicação que os manuscritos submetidos a esta revista não tenham sido publicados anteriormente e não sejam submetidos ou publicados simultaneamente em outro periódico sem prévia autorização do Conselho Editorial. - Os autores concordam que o seu artigo ou parte dele possa ser distribuído e/ou reproduzido por qualquer forma, incluindo traduções, desde que sejam citados de modo completo esta revista e os autores do manuscrito. - Revista Cadernos de Prospecção está licenciado com uma Licença Creative Commons Attribution 4.0. Esta licença permite que outros remixem, adaptem e criem a partir do seu trabalho para fins não comerciais, e embora os novos trabalhos tenham de lhe atribuir o devido crédito e não possam ser usados para fins comerciais, os usuários não têm de licenciar esses trabalhos derivados sob os mesmos termos.
Este obra está licenciado com uma Licença Creative Commons Atribuição 4.0 Internacional.
